Skip to main content
Clinical Trials/NCT02390453
NCT02390453
Completed
N/A

Cognitive and Aerobic Resilience for the Brain

Indiana University1 site in 1 country201 target enrollmentJanuary 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Mild Cognitive Impairment
Sponsor
Indiana University
Enrollment
201
Locations
1
Primary Endpoint
Average participant self-ratings of intervention acceptability.
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This is a randomized controlled trial (RCT) of the effectiveness of cognitive and exercise training versus control condition on cognitive function in older adults with mild cognitive impairment (MCI).

Detailed Description

Exercise and cognitive training hold promise for delaying progression of MCI. Exercise improves cognitive ability, brain function, and brain structure in older adults. Cognitive training has been shown to durably improve mental abilities and functional status in older adults. In addition, persons with MCI respond to some forms of cognitive training just as robustly as healthy older adults. This pilot study is a 4 group design with a home-based multi-modal physical exercise intervention, cognitive training, combined cognitive and physical training, and a social contact control enrolling older adults with MCI. This pilot study is designed to be consistent with current recommended approaches to establishing trial feasibility. If the aims are achieved, it will provide a conceptual and practical rationale to support a large, multi-site, randomized clinical trial to test the efficacy of combined physical and cognitive training in delaying time to a clinical diagnosis of dementia.

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
October 25, 2019
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Frederick Unverzagt

Professor

Indiana University

Eligibility Criteria

Inclusion Criteria

  • subjective memory complaint
  • minimal impairment in daily function per Functional Activity Questionnaire (FAQ)
  • sedentary
  • English speaking
  • access to telephone

Exclusion Criteria

  • dementia or Alzheimer disease
  • stroke, past 12 months
  • myocardial infarction, past 12 months
  • Parkinson disease
  • multiple sclerosis
  • brain tumor, infection, or surgery
  • brain injury with \> 30 minute LOC
  • schizophrenia
  • bipolar disorder
  • cancer with short life expectancy

Outcomes

Primary Outcomes

Average participant self-ratings of intervention acceptability.

Time Frame: From date of randomization until the date of the final training session or the end of the 12-week intervention, whichever came first.

Average of individual Likert self-ratings of the interventions (where 1 = very unenjoyable, 2 = not enjoyable, 3 = neutral, 4 = enjoyable, and 5 = very enjoyable) for each session of the 12-week intervention.

Participant adherence to treatment.

Time Frame: From date of randomization until the date of the final training session or the end of the 12-week intervention, whichever came first.

Number of training sessions attended divided by the the total number of sessions available.

Participant adherence to outcome assessment.

Time Frame: End of treatment at 12-weeks.

Number of participants completing the post-training outcome assessment divided by the total number randomized.

Cognitive function composite score as measured by individually-administered tests of psychomotor speed, complex sequencing, and list learning.

Time Frame: End of treatment at 12-weeks.

The cognitive composite is derived from: WAIS-IV Symbol Search, Trail Making Test Part B, and Rey Auditory Verbal Learning Test.

Number of participants with study-related adverse events (AE) by treatment arm.

Time Frame: From enrollment through end of treatment at 12-weeks.

Study Sites (1)

Loading locations...

Similar Trials